The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of a novel antibody-drug conjugate (ADC), ABT-414, as monotherapy in epidermal growth factor receptor (EGFR) amplified, recurrent glioblastoma (GBM).
 
Martin J. Van Den Bent
Consulting or Advisory Role - Abbvie; Actelion; Amgen; Blue Earth Diagnostics; Bristol-Myers Squibb; Cavion; Celldex; Merck; Novartis; Novocure; Roche
Research Funding - Abbvie (Inst); Roche (Inst)
 
Hui Kong Gan
Consulting or Advisory Role - AbbVie; Merck Serono
Research Funding - AbbVie
Travel, Accommodations, Expenses - AbbVie; Merck Sharp & Dohme
 
Andrew B. Lassman
Consulting or Advisory Role - Abbvie; Celgene; Cortice Biosciences; Foundation Medicine; Genentech/Roche; HERON; Midatech Pharma; Novartis; Oxigene; Regeneron
Research Funding - Abbvie (Inst); Aeterna Zentaris (Inst); Agenus (Inst); Amgen (Inst); Bayer/Onyx (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); e-Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); ImmunoCellular Therapeutics (Inst); Karyopharm Therapeutics (Inst); MedImmune (Inst); Merck (Inst); Millennium (Inst); Northwest Biotherapeutics (Inst); Novartis (Inst); Novocure (Inst); Novocure (Inst); Pfizer (Inst); Plexxikon (Inst); Regeneron (Inst); Stemline Therapeutics (Inst); Tocagen (Inst); VBL Therapeutics (Inst)
 
Priya Kumthekar
Consulting or Advisory Role - Abbvie
 
Ryan Merrell
No Relationships to Disclose
 
Nicholas A. Butowski
Honoraria - Medicenna; omniox; Roche/Genentech; VBL Therapeutics
Consulting or Advisory Role - Medicenna; omniox; Roche/Genentech; VBL Therapeutics
Speakers' Bureau - Merck; Roche
Research Funding - Insys Therapeutics
 
Zarnie Lwin
No Relationships to Disclose
 
Tom Mikkelsen
Honoraria - Roche/Genentech
Consulting or Advisory Role - Orbus Therapeutics; Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Louis B. Nabors
Consulting or Advisory Role - Cavion
 
Kyriakos P. Papadopoulos
Research Funding - Abbvie; Daiichi Sankyo; GlaxoSmithKline; MedImmune; Novartis; Onyx; Sanofi
 
Marta Penas-Prado
No Relationships to Disclose
 
John Simes
No Relationships to Disclose
 
Helen Wheeler
No Relationships to Disclose
 
Erica J. Gomez
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Ho-Jin Lee
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Lisa Roberts-Rapp
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Hao Xiong
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Earle E. Bain
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Kyle D. Holen
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
David A. Reardon
Honoraria - Abbvie; Bristol-Myers Squibb; Cavion; Celldex; Genentech/Roche; Inovio Pharmaceuticals; Juno Therapeutics; Merck; Midatech Pharma; Momenta Pharmaceuticals; Monteris Medical; Novartis; Novocure; Oxigene; Regeneron; Stemline Therapeutics
Consulting or Advisory Role - Bristol-Myers Squibb; Cavion; Celldex; Genentech/Roche; Inovio Pharmaceuticals; Juno Therapeutics; Merck; Midatech Pharma; Momenta Pharmaceuticals; Monteris Medical; Novartis; Novocure; Oxigene; Regeneron; Stemline Therapeutics
Research Funding - Celldex (Inst); Incyte (Inst); Midatech Pharma (Inst)